Additional evidence to support the phasing-out of treatment category II regimen for pulmonary tuberculosis in Peru

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 106, Issue 8, 2012, Pages 508-510

  Ponce, Mario ^a   Ugarte Gil, Cesar ^a   Zamudio, Carlos ^a   Krapp, Fiorella ^a   Gotuzzo, Eduardo ^a,b   Seas, Carlos ^a,b  

^a INSTITUTO DE MEDICINA TROPICAL ALEXANDER VON HUMBOLDT   (Peru)

^b HOSPITAL NACIONAL CAYETANO HEREDIA   (Peru)

Author keywords

Drug therapy; Failure; Multi drug resistance; Streptomycin; Treatment outcome; Tuberculosis

Indexed keywords

RIFAMPICIN; STREPTOMYCIN;

ADULT; ARTICLE; CONVALESCENCE; FEMALE; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; PERU; PRACTICE GUIDELINE; PREVALENCE; TREATMENT FAILURE; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

ADULT; ANTITUBERCULAR AGENTS; DRUG ADMINISTRATION SCHEDULE; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MALE; PERU; PRACTICE GUIDELINES AS TOPIC; STREPTOMYCIN; TREATMENT FAILURE; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY; WORLD HEALTH ORGANIZATION;

EID: 84863579155     PISSN: 00359203     EISSN: 18783503     Source Type: Journal    
DOI: 10.1016/j.trstmh.2012.05.008     Document Type: Article

References (7)

1. WHO. Global tuberculosis control-a short update to the 2009 report. Geneva: World Health Organization; 2009.
2. Velásquez G.E., Yagui M., Cegielski J.P., et al. Targeted drug-resistance strategy for multidrug-resistant tuberculosis detection, Lima, Peru. Emerg Infect Dis 2011, 17:432-440.
3. National Sanitary Strategy, National Tuberculosis Control Program. Situation of tuberculosis in Peru. [accessed 23 January 2012]. http://www.minsa.gob.pe/portada/Especiales/2011/respiravida/archivos/Ayuda_memoria_Lanzamiento_TB.pdf.
4. Acuña-Villaorduña C., Vassall A., Henostroza G., et al. Cost-effectiveness analysis of introduction of rapid, alternative methods to identify multi-drug-resistant tuberculosis in middle-income countries. Clin Infect Dis 2008, 47:487-495.
5. Jones-López E.C., Ayakaka I., Levin J., et al. Effectiveness of the standard WHO recommended retreatment regimen (category II) for tuberculosis in Kampala, Uganda: a prospective cohort study. PLoS Med 2011, 8:e1000427.
6. Saravia J.C., Appleton S.C., Rich M.L., Sarria M., Bayona J., Becerra M.C. Retreatment management strategies when first-line tuberculosis therapy fails. Int J Tuberc Lung Dis 2005, 9:421-429.
7. Nabeta P., Henostroza, Seas C., Gotuzzo E. Drug resistance among smear positive pulmonary tuberculosis patients in a high prevalence area in Lima, Peru. Int J Tuberc Lung Dis 2006, 10(Suppl):S254-S255.